About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Psychiatry, Mental Health and Addictions Research Group at the Vall d'Hebron Research Institute is a multidisciplinary team that over the past 13 years has focused its scientific activity on the research (both nationally and internationally) of clinical, therapeutic and etiopathogenic aspects of:
At international level, it participates and/or coordinates several European projects of great repercussion in the area of mental health. At national level, it is part of the CIBERSAM (Centre for Biomedical Research in Mental Health Network) together with other leading groups, conducting research of excellence.
IP: Mª Dolores Braquehais Conesa Collaborators: Marta Quesada Franco, Gemma Parramon Puig, Anna Beneria González, Gara Arteaga Henriquez Funding agency: Fundació La Marató de TV3 Funding: 128400 Reference: 202208-30-31 Duration: 20/04/2023 - 31/12/2026
IP: Marta Ribases Haro Collaborators: Judit Cabana Dominguez, José Antonio Ramos Quiroga, Laura Gisbert Gustemps, Gemma Español Martín, Vanesa Richarte Fernández, Silvia Alemany Sierra, Natalia Llonga Tejedor, Maria Soler Artigas Funding agency: Fundació La Marató de TV3 Funding: 199187.5 Reference: 202228-30-31 Duration: 20/04/2023 - 31/12/2026
IP: Silvia Amoretti Guadall Collaborators: Miguel Angel Sandonis Vicente, Gemma Parramon Puig, Javimar Suarez Jesus Funding agency: Fundació La Marató de TV3 Funding: 50049.25 Reference: 202234-32 Duration: 19/05/2023 - 31/12/2026
IP: Amanda Rodríguez Urrutia Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Gemma Nieva Rifa, Marta Gil Gordillo, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC, Silvia Ferrer Moltó, Jordi Morillas Ros, Núria Gallardo Hernández, Julia Vendrell Serres, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC, Gina Aliaga Montané, Thaïs Gabriel Aranega, Laia Anglada Llistosella, Sara García González, Imanol Setien Ramos, Active Comparator-controlled, Clinical Trial to Study the Efficacy and Safety of the INtegral Cognitive REMediation program (INC Funding agency: Fundació La Marató de TV3 Funding: 60872.31 Reference: 202227-30-31-32-33 Duration: 30/04/2023 - 30/04/2026
Over the course of one week, it will host in-person assessments for 35 families to better understand the progression of the disease and contribute to the development of new therapies.
A project led by the Vall d’Hebron Research Institute (VHIR) in collaboration with FIDMAG Germanes Hospitalàries Research Foundation describes structural and functional brain changes in adolescents with borderline personality disorder (BPD).
A large-scale study involving Vall d’Hebron confirms the genetic relatedness among 14 different psychiatric disorders and groups them into five new families, paving the way for new treatments targeting their shared underlying genetic causes
